Head to Head Survey: Itron (NASDAQ:ITRI) vs. MyDx (OTCMKTS:MYDX)

Itron (NASDAQ:ITRI) and MyDx (OTCMKTS:MYDX) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Itron and MyDx, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itron	0	3	9	0	2.75
MyDx	0	0	0	0	N/A

Itron presently has a consensus target price of $95.60, suggesting a potential upside of 4.53%. Given Itron’s higher probable upside, equities research analysts clearly believe Itron is more favorable than MyDx.

Profitability

This table compares Itron and MyDx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Itron	4.46%	12.27%	6.11%
MyDx	N/A	N/A	N/A

Earnings and Valuation

This table compares Itron and MyDx’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itron	$2.17 billion	1.93	$96.92 million	$2.10	43.55
MyDx	N/A	N/A	N/A	N/A	N/A

Itron has higher revenue and earnings than MyDx.

Insider & Institutional Ownership

96.2% of Itron shares are held by institutional investors. 1.5% of Itron shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Itron beats MyDx on 8 of the 8 factors compared between the two stocks.

About Itron

Itron, Inc., a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products. The Networked Solutions segment provides communicating devices, such as smart meters, modules, endpoints, and sensors; network infrastructure; and associated heat-end management and application software for acquiring and transporting application-specific data. This segment also offers industrial internet of things solutions. Including automated meter reading; advanced metering infrastructure for electricity, water, and gas; distributed energy resource management; smart grid and distribution automation; smart street lighting; and leak detection and applications for gas and water systems. The Outcomes segment provides value-added, enhanced software and services, artificial intelligence, and machine learning for managing, organizing, analyzing, and interpreting data to enhance decision making, maximize operational profitability, resource efficiency, grid analytics, and deliver results for consumers, utilities, and smart cities. In addition, it offers implementation, project management, installation, consulting, and post-sale maintenance support services, as well as cloud and software-as-a-service; and extended or customer-specific warranties. The company offers its products and services under the Itron brand. It serves utility and smart city customers, and municipalities through its sales force, distributors, agents, partners, and meter manufacturer representatives. Itron, Inc. was incorporated in 1977 and is headquartered in Liberty Lake, Washington.

About MyDx

MyDx, Inc. is a science and technology company, which engages in the development and deployment of products and services in the areas of consumer products, data analytics, biopharmaceutical, and software as a service. Its product, MyDx, is a patented multiuse hand-held chemical analyzer designed to help consumers and professional test for pesticides in food, chemicals in water, toxins in the air, and safety and potency of cannabis samples. The company was founded by Daniel Rida Yazbeck on December 20, 2012 and is headquartered in San Diego, CA.